Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Dupixent
Dupixent
Regeneron has a winner in Dupixent and big sales hopes. So why are so few patients taking it?
Endpoints
Mon, 02/8/21 - 10:25 am
Dupixent
Regeneron
Sanofi
eczema
Pfizer, still chasing Dupixent, releases fifth round of data for eczema JAK inhibitor abrocitinib
Endpoints
Wed, 11/11/20 - 11:04 am
Pfizer
JAK inhibitors
abrocitinib
Dupixent
atopic dermatitis
clinical trials
Sanofi, despite COVID-19, sees early gains from CEO Hudson's strategy revamp
Fierce Pharma
Thu, 10/29/20 - 12:19 pm
Sanofi
earnings
Dupixent
Paul Hudson
Pharma CEOs
Sanofi, Regeneron chase 4th Dupixent approval with rare esophageal disease data
Fierce Pharma
Mon, 10/26/20 - 11:04 pm
Sanofi
Regeneron
FDA
Dupixent
eosinophilic esophagitis
Dupixent Posts Positive Results in Phase III Pediatric Asthma Study
BioSpace
Tue, 10/13/20 - 11:06 am
Regeneron
Sanofi
pediatric
asthma
clinical trials
Dupixent
Sanofi, Regeneron get FDA breakthrough therapy status for Dupixent to treat eosinophilic esophagitis
Pharmaceutical Business Review
Mon, 09/14/20 - 10:50 am
Sanofi
Regeneron
Dupixent
FDA
eosinophilic esophagitis
breakthrough status
Can Sanofi's top drug carry it through a pandemic?
BioPharma Dive
Wed, 07/29/20 - 01:16 pm
Sanofi
Dupixent
earnings
pandemic
COVID-19
Leo Pharma offloads a psoriasis asset as their Dupixent rival heads to the FDA
Endpoints
Tue, 07/21/20 - 10:27 am
LEO Pharma
psoriasis
Sanofi
Dupixent
LP0058
LEO eyeing 2021 US launch for eczema drug tralokinumab
Pharmaforum
Fri, 07/10/20 - 10:47 am
LEO Pharma
eczema
tralokinumab
Sanofi
Dupixent
Sanofi, Regeneron Win China Approval For Dupixent Dermatitis Drug
Yahoo/SmarterAnalyst
Mon, 06/22/20 - 10:30 am
Sanofi
Regeneron
China
Dupixent
atopic dermatitis
New safety data expose potential weakness as Pfizer's abrocitinib takes on Dupixent in eczema
Endpoints
Thu, 06/4/20 - 11:15 am
Pfizer
abrocitinib
Dupixent
clinical trials
eczema
Sanofi and Regeneron's Dupixent Scores Another Approval for Dermatitis, This Time in Kids
BioSpace
Wed, 05/27/20 - 10:47 am
Sanofi
Regeneron
Dupixent
atopic dermatitis
pediatric
Dupixent clears PhIII trial in new disease as blockbuster looks to expand past Regeneron-Sanofi split
Endpoints
Wed, 05/27/20 - 10:27 am
Dupixent
Sanofi
Regeneron
esosinophilic esophagitis
EoE
clinical trials
Does Regeneron Pharmaceuticals’ Winning Streak Signal Irrational Exuberance?
Motley Fool
Fri, 04/24/20 - 10:59 am
Regeneron
Eylea
Dupixent
Aslan's Dupixent rival test put on hold amid COVID-19, but delays shouldn't hit readout
Fierce Biotech
Mon, 04/13/20 - 10:57 am
Aslan Pharma
ASLAN004
Regeneron
Sanofi
Dupixent
atopic dermatitis
Sanofi and Regeneron's Dupixent shows more encouraging results
Reuters
Fri, 04/3/20 - 06:38 pm
Sanofi
Dupixent
atopic dermatitis
clinical trials
Will Eczema Drug Dupixent Transform Sanofi?
Motley Fool
Thu, 02/13/20 - 10:53 am
Sanofi
Dupixent
Paul Hudson
Sanofi’s Dupixent funded in Wales and Scotland for adolescents with eczema
Pharmaforum
Mon, 01/27/20 - 10:38 am
Sanofi
Dupixent
NHS
Wales
Scotland
atopic dermatitis
Upcoming events – Pfizer's abrocitinib and Myovant's relugolix
EP Vantage
Sat, 01/11/20 - 12:01 am
Pfizer
abrocitinib
Dupixent
Sanofi
Myovant
Relugolix
uterine fibroids
Leo's Dupixent rival hits all endpoints in pivotal program
Fierce Biotech
Wed, 12/11/19 - 10:36 am
LEO Pharma
atopic dermatitis
tralokinumab
Sanofi
Regeneron
Dupixent
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
next ›
last »